High levels of circulating IL-6 during the acute phase of sepsis are associated with a high risk of mortality, and analgesic treatment could be effective for high responders with excessive immune responses, explaining the reduced mortality observed with meloxicam treatment in PCI sepsis mice. This evidence concerns the gene IL6 and Sepsis.